This inventor holds 2 USPTO granted patents. Top assignee: Alchemedicine, Inc.. Active years: 2025-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025-2026
Title: Tomohisa Ninomiya: Innovator in Pharmaceutical Composition
Introduction
Tomohisa Ninomiya is a notable inventor based in Tsukuba, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that activate aldehyde dehydrogenase 2 (ALDH2). His work has the potential to impact therapeutic and prophylactic treatments.
Latest Patents
Ninomiya holds a patent for a compound, aldehyde dehydrogenase 2 activating agent, pharmaceutical composition, and therapeutic and/or prophylactic drug. This patent includes a compound that exhibits an activation effect on ALDH2, which is crucial for various metabolic processes. The compound is represented by a specific formula, and it includes pharmaceutically acceptable salts or prodrugs.
Career Highlights
He is currently associated with Alchemedicine, Inc., where he continues to innovate in the pharmaceutical sector. His work focuses on enhancing the efficacy of therapeutic agents through the activation of key enzymes.
Collaborations
Ninomiya collaborates with Keigo Tanaka, contributing to advancements in their shared field of research.
Conclusion
Tomohisa Ninomiya's contributions to pharmaceutical innovations, particularly through his patent on ALDH2 activating agents, highlight his role as a significant inventor in the industry. His ongoing work promises to lead to important developments in therapeutic applications.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile